This is the authors' abstract. We don't add key points for this paper.
Activation of Nrf2 by directly inhibiting the Keap1–Nrf2 Protein–Protein Interaction (PPI) has gained research interest with regard to developing novel agents for treating inflammatory related diseases.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: